Spruce Biosciences (SPRB) Earnings Date & Reports

Spruce Biosciences Inc is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with unmet medical needs... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

SPRB is expected to report earnings to fall 93.86% to -21 cents per share on November 17

Spruce Biosciences SPRB Stock Earnings Reports

Q3'25

Est.

$-0.22

Q2'25

Missed

by $3.24

Q1'25

Missed

by $0.15

Q4'24

Missed

by $0.36

Q3'24

Beat

by $0.03

The last earnings report on August 08 showed earnings per share of -350 cents, missing the estimate of -25 cents. With 10.88K shares outstanding, the current market capitalization sits at 3.32M.

View a ticker or compare two or three

Compare

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. SPRB showed earnings on August 08, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

611 Gateway Boulevard

Phone

+1 415 655-4168

Employees

Web

https://www.sprucebiosciences.com